Active glycation in neurofibrillary pathology of Alzheimer disease: Nε-(Carboxymethyl) lysine and hexitol-lysine
- 29 June 2001
- journal article
- Published by Elsevier in Free Radical Biology & Medicine
- Vol. 31 (2) , 175-180
- https://doi.org/10.1016/s0891-5849(01)00570-6
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Glycoxidation in aortic collagen from STZ-induced diabetic rats and its relevance to vascular damageAtherosclerosis, 1998
- Increased accumulation of the glycoxidation product N(epsilon)-(carboxymethyl)lysine in human tissues in diabetes and aging.Journal of Clinical Investigation, 1997
- Glycoxidation and oxidative stress in Parkinson disease and diffuse Lewy body diseaseBrain Research, 1996
- Quantitative solubilization and analysis of insoluble paired helical filaments from alzheimer diseaseBrain Research, 1996
- Nε-(Carboxymethyl)lysine Protein Adduct Is a Major Immunological Epitope in Proteins Modified with Advanced Glycation End Products of the Maillard ReactionBiochemistry, 1996
- N.epsilon.-(Carboxymethyl)lysine Is a Dominant Advanced Glycation End Product (AGE) Antigen in Tissue ProteinsBiochemistry, 1995
- Glycated tau protein in Alzheimer disease: a mechanism for induction of oxidant stress.Proceedings of the National Academy of Sciences, 1994
- Advanced Maillard reaction end products are associated with Alzheimer disease pathology.Proceedings of the National Academy of Sciences, 1994
- Advanced glycation end products contribute to amyloidosis in Alzheimer disease.Proceedings of the National Academy of Sciences, 1994
- Age-dependent accumulation of N.epsilon.-(carboxymethyl)lysine and N.epsilon.-(carboxymethyl)hydroxylysine in human skin collagenBiochemistry, 1991